PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2011

Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 21839124 ↗2011Reported benefit

Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo.

MouseIschaemia-reperfusionCardiacC57BLIntravenous1 mg/kg5 min before reperfusion

Model: Myocardial ischaemia-reperfusion injury

A single low dose of CPP-BH4 peptide reduced infarct size by about 47% and apoptosis by about 60% after cardiac ischaemia-reperfusion.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.